Furanodienone overcomes temozolomide resistance in glioblastoma through the downregulation of CSPG4‐Akt‐ERK signalling by inhibiting EGR1‐dependent transcription-Reference-Cited by-同舟云学术

Furanodienone overcomes temozolomide resistance in glioblastoma through the downregulation of CSPG4‐Akt‐ERK signalling by inhibiting EGR1‐dependent transcription

Published:2019-04-21 Issue:6 Volume:33 Page:1736-1747
ISSN:0951-418X
Container-title:Phytotherapy Research
language:en
Short-container-title:Phytotherapy Research

Author:

Chen Lei¹,Liu Yue‐cheng¹,Zheng Yue‐yang¹,Xu Ji¹,Zhang Yuan¹,Liu Wen‐lan¹,Li Zong‐yang¹,Huang Guo‐dong¹,Li Wei‐ping¹^ORCID

Affiliation:

1. Department of Neurosurgery, Shenzhen Key Laboratory of Neurosurgerythe First Affiliated Hospital of Shenzhen University, Shenzhen Second People's Hospital 3002# Sungang Road, Futian District Shenzhen 518035 China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ptr.6363

Reference49 articles.

1. Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials

2. A novel approach for targeted elimination of CSPG4-positive triple-negative breast cancer cells using a MAP tau-based fusion protein

3. The regulatory mechanisms of NG2/CSPG4 expression